Premium
Molecular Devices (MM) (MDCC)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
SUNNYVALE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) today announced revenues and earnings for the quarter and year ended December 31, 2006. Revenues...
- New MDS business unit offers broader array of customer solutions by combining leadership positions in Mass Spectrometry and Cellular Analysis SUNNYVALE, Calif. and TORONTO, Jan. 29...
SUNNYVALE, Calif., Jan. 26 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced...
SUNNYVALE, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced...
SUNNYVALE, Calif., Jan. 10 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced...
SUNNYVALE, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) today announced revenues and earnings for the quarter ended September 30, 2006. Revenues for the...
SUNNYVALE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) will announce its third quarter 2006 earnings on Thursday, October 26, 2006 after the close of...
SUNNYVALE, Calif., Sept. 27 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) today updated guidance for the third quarter of 2006. As a result of softer than expected...
HAYWARD, Calif., Sept. 26 /PRNewswire/ -- Multispan Inc., a technology platform company specializing in G-Protein-Coupled Receptor (GPCR) research, today announced the launch of a series of...
SUNNYVALE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
